{
  "id": 1532,
  "text": "It should be noted that at the time of analysis, there were no increases in late side effects.The second one1435,1490-1492 showed significant improvement in PFS and OS among those who received concurrent chemoradiotherapy plus adjuvant chemotherapy compared with those given concurrent chemoradiotherapy alone $\\mathrm { \\Delta } [ \\mathrm { H R } = 0 .",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: It should be noted that at the time of analysis, there were no increases in late side effects.The second one1435,1490-1492 showed significant improvement in PFS and OS among those who received concurrent chemoradiotherapy plus adjuvant chemotherapy compared with those given concurrent chemoradiotherapy alone $\\mathrm { \\Delta } [ \\mathrm { H R } = 0 .\n\n<question>: ",
  "ChatGPT_response_0": "根据研究结果显示，同时接受放化疗和辅助化疗的患者在生存率和进展生存期方面有明显的改善。研究表明，接受同时放化疗和辅助化疗的患者相比于只接受同时放化疗的患者，在进展生存期（PFS）和总生存期（OS）方面有显著提高。值得注意的是，在分析时，并未发现晚期副作用的增加。这些结果表明，对于某些患者，接受放化疗和辅助化疗的联合治疗可能会带来更好的生存和治疗效果。",
  "query": "在这项研究中，是否发现同时接受放化疗和辅助化疗的患者在生存率和进展生存期方面有明显的改善？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在这项研究中，是否发现同时接受放化疗和辅助化疗的患者在生存率和进展生存期方面有明显的改善？\n\n<reference text>: It should be noted that at the time of analysis, there were no increases in late side effects.The second one1435,1490-1492 showed significant improvement in PFS and OS among those who received concurrent chemoradiotherapy plus adjuvant chemotherapy compared with those given concurrent chemoradiotherapy alone $\\mathrm { \\Delta } [ \\mathrm { H R } = 0 .\n\n<reply>: ",
  "response": "根据研究结果显示，同时接受放化疗和辅助化疗的患者在生存率和进展生存期方面有明显的改善。研究表明，接受同时放化疗和辅助化疗的患者相比于只接受同时放化疗的患者，在进展生存期（PFS）和总生存期（OS）方面有显著提高。值得注意的是，在分析时，并未发现晚期副作用的增加。这些结果表明，对于某些患者，接受放化疗和辅助化疗的联合治疗可能会带来更好的生存和治疗效果。"
}